Submit papers to the magazine

Instructions to authors

 

Genomic Medicine is a new biomedical journal that will publish original papers on all issues related to genomic medicine. Dr. Gerardo Jimenez Sanchez, Director General of the National Institute of Genomic Medicine (INMEGEN), is the Regional Editor for Latin America and the Caribbean.

The main purpose of the magazine is to be an important vehicle for the publication of a wide range of research projects and papers in the field of genomics and its implications to the current and future clinical practice of medicine and public health. The scope of the magazine reflects the rapid natural expansion of the genomic field.

The journal receives articles and papers focused on three categories:

• - Advances in knowledge and development of genomics-related fields such as the implications to medicine and public health. For example, the journal icontains papers on basic biology, molecular biology, genomic epidemiology, clinical proteomics, microbial genomics, comparative genomics, high technology genomics, bioinformatics, pharmacogenomics, nutrigenomics, clinical therapy, toxicogenomics, individualized medicine, genomics in cancer, and population genomics.

• - Transfer of genome research in order to understand the medical complexity of diseases (for instance, coronary artery disease, diabetes mellitus, asthma, cancer, skin disease, and pediatric diseases).

• - Applications of science and genome biotechnology in infections. For example, susceptibility – protection; antimicrobial therapy and development of new vaccines.

• - Development and evaluation of new drugs, including the favorable or adverse response to pharmacological and toxic substances.

• - Impact of genomic medicine on the community and public health.

• - Social and behavioral issues related to practicing genomic medicine.

• - Debate and discussion on ethical, legal and social aspects related to genomic medicine.

     - Discussions about case studies supported by therapeutic and diagnostic procedures.

• - Reports and discussions on books, human genome conferences and genomic medicine.

The journal will not consider research papers about basic genomics, isolated clinical cases, frequency of population polymorphism, gene mapping of unknown functions, unless they raise scientific interest due to an unusual feature or disorder that leads to an increased biological understanding of the process and can be applied to common disorders.